BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

  April 16, 2025

   · 

  4 min read
• Press Releases

  Remix Therapeutics Appoints Linda C. Bain to Board of Directors

  April 16, 2025

   · 

  2 min read
• Press Releases

  Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model

  April 16, 2025

   · 

  7 min read
• Press Releases

  Baylink Biosciences To Highlight New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting

  April 16, 2025

   · 

  4 min read
• Press Releases

  Repligen to Report First Quarter 2025 Financial Results

  April 16, 2025

   · 

  2 min read
• Press Releases

  Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases

  April 16, 2025

   · 

  7 min read
• Press Releases

  Attovia Therapeutics Announces $90 Million Series C Financing to Advance ATTOBODY-based Programs through Clinical Proof of Concept

  April 16, 2025

   · 

  3 min read
• Press Releases

  Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

  April 16, 2025

   · 

  8 min read
• Press Releases

  Biocon Biologics Secures Market Entry Date for Yesafili™, an Interchangeable Biosimilar to Eylea®, in the U.S.

  April 16, 2025

   · 

  7 min read
• Press Releases

  Norgine strengthens rare disease portfolio with acquisition of Theravia

  April 16, 2025

   · 

  7 min read